Tracked deals
15
15 tracked deals across 2020-2026.
London, United Kingdom
London-based private equity firm managing over £500m with a value-based, operationally focused strategy. Limerston invests in control investments in lower mid-market UK companies (typically £50m–£175m enterprise value) across sectors including Business Services, Consumer & Leisure, Education, Healthcare & Life Sciences, and Industrial & Niche Manufacturing & Testing.
Tracked deals
15
15 tracked deals across 2020-2026.
Recent pace
1
1 tracked deal announced in the last 12 months.
Deal mix
Addon
13 addon · 2 divestiture
Last 7 years
Supporting Data
Showing the 12 most recent of 15 tracked deals for Limerston Capital.
Limerston Capital portfolio company Empowering People Group has entered into a definitive agreement to acquire Mentor Advisory Services Ltd from NatWest Group. The acquisition will add Mentor’s Employment Law, HR, health and safety, environmental and digital compliance capabilities to Empowering People’s buy-and-build platform and is expected to complete in Q3 2026.
Limerston Capital has added DigitalXRAID, an award-winning UK managed security services provider (MSSP), to its cybersecurity platform as an add-on acquisition. The deal expands the group's SOC, managed services, digital forensics and incident response capabilities and follows Limerston's May acquisition of CyberCrowd as part of a buy-and-build strategy to create a leading UK cyber security group.
Limerston Capital‑backed Concept Life Sciences (CLS) has acquired Charnwood Discovery, a UK-based drug discovery contract research provider headquartered in Loughborough. The add-on strengthens CLS's integrated drug discovery, chemistry, biology and ADME/DMPK capabilities and expands its ability to accelerate drug candidates to clinic while providing customers access to CLS's broader translational biology and GMP manufacturing services.
London-based private equity firm Limerston Capital has acquired UK-based cyber security services specialist CyberCrowd as the first step in building a new cybersecurity platform alongside assets from an earlier acquisition. The combined group will offer digital forensics, e-Discovery, a proprietary forensic case management tool, a 24/7 UK-based SOC, incident response, and scaled consultancy and penetration testing services to public and private sector clients.
UK-based Cormica, backed by Limerston Capital, has acquired TPM Laboratories, an independent contract testing laboratory in Cherry Hill, New Jersey. The seven-figure, add-on purchase expands Cormica's analytical testing capabilities and establishes its first US presence while TPM's founder, Rupa Iyer, will continue to lead the US operation.
Limerston Capital portfolio company Largo Leisure Holidays has acquired Campsie Glen Holiday Park in Fintry, Stirlingshire, adding a site with over 200 pitches and planning permission for further development to its Scottish parks portfolio. The transaction is a bolt-on acquisition supporting Largo's acquisitive growth plan since Limerston acquired Largo in March 2022 and follows the firm's earlier addition of Cruachan Farm in June 2023.
Cormica, a Limerston Capital‑backed life sciences testing group, has acquired Zwisler Laboratorium, a Reichenau, Germany–based laboratory specialising in microbiological and in‑vitro testing. The deal gives Cormica its first foothold in Germany and expands its capabilities for pharmaceutical, biotech, medical device and packaging customers across Europe.
Forensic Access Group, a portfolio company of Limerston Capital, has acquired FTS (Forensic Testing Service), a West Yorkshire–based toxicology testing provider focused on family law and childcare proceedings. The transaction is the fifth bolt-on to Forensic Access’s platform and is intended to expand toxicology capacity, capabilities and diversify the group’s client base.
Limerston Capital portfolio company Largo Leisure Holidays has acquired Cruachan Farm, a holiday park adjacent to Largo Leisure's Loch Tay property, as its first bolt-on under an acquisitive growth plan. The sites will remain separately branded but will benefit from operational synergies and shared optimisation efforts across Largo Leisure's Scottish park portfolio.
Limerston Capital LLP has acquired Concept Life Sciences, a UK-based contract research organisation (CRO), in a carve-out from Spectris plc through its new fund Limerston Capital Partners II. The deal provides Concept Life Sciences with independent ownership, new leadership under CEO Dr Ben Cliff and additional investment to support growth across its drug discovery, development and API manufacturing services. Limerston intends to use the business as a platform for further buy-and-build and operational expansion in the life sciences sector.
Limerston Capital has acquired Source BioScience's Stability Storage business (renamed Astoriom) from Source BioScience. The UK-headquartered biorepository specialist, based in Rochdale with 33 employees, will be developed as a platform for buy-and-build expansion into the US and European pharmaceutical and biologics markets.
Empowering People Group, a Limerston Capital-backed human capital management platform, has acquired Learning Nexus, a Gloucester-based provider of compliance-led online learning and LMS solutions. The bolt-on purchase expands Empowering People Group's digital learning capabilities and recurring subscription-based revenue while broadening its customer offering to corporates, public sector organisations and non-profits.
Turn tracked acquisition activity into an outreach-ready buyer list.